Treatment of Influenza and ARVI in Children by Kagocel ®
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Kagocel® for the Prevention of ARVI and Influenza in Young People
- Status
- COMPLETED
- Phase
- N/A
Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness
- Status
- COMPLETED
- Phase
- PHASE2
A Study of HNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1
Performance Feedback in Health Care
- Status
- COMPLETED
- Phase
- NA
Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults
- Status
- COMPLETED
- Phase
- PHASE2
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
- Status
- COMPLETED
- Phase
- N/A
Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Elderly
- Status
- UNKNOWN
- Phase
- PHASE3
Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age
- Status
- TERMINATED
- Phase
- PHASE3
Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- UCLA Portal R/R Influenza RCT 3
- Status
- COMPLETED
- Phase
- NA
Influenza Vaccine in Lung Transplant Patients - Antibody
- Status
- COMPLETED
- Phase
- N/A
Influenza Vaccine in Lung Transplant Patients - T Cells
- Status
- COMPLETED
- Phase
- N/A
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
- Status
- COMPLETED
- Phase
- N/A
Influenza Vaccine in Lung Transplant Patients - Seroprotection
- Status
- COMPLETED
- Phase
- N/A
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
- Status
- COMPLETED
- Phase
- N/A
Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel
- Status
- COMPLETED
- Phase
- PHASE4